NCT02427360View on ClinicalTrials.gov

Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers

CompletedOBSERVATIONAL
Enrollment

1,022

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
P. Falciparum MalariaP. Falciparum Malaria Mixed Infection
Trial Locations (1)

Unknown

Shoklo Malaria Research Unit, Mae Sot

All Listed Sponsors
collaborator

Texas Biomedical Research Institute

UNKNOWN

collaborator

Nanyang Technological University

OTHER

lead

University of Oxford

OTHER

NCT02427360 - Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers | Biotech Hunter | Biotech Hunter